BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2532074)

  • 1. Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
    Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K
    Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
    Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
    Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian fluctuations of tissue plasminogen activator antigen and plasminogen activator inhibitor-1 antigens in vasospastic angina.
    Sakata K; Hoshino T; Yoshida H; Ono N; Ohtani S; Yokoyama S; Mori N; Kaburagi T; Kurata C; Urano T
    Am Heart J; 1992 Oct; 124(4):854-60. PubMed ID: 1529901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does exercise-induced myocardial ischaemia cause enhanced platelet activation and fibrin formation in patients with stable angina and severe coronary artery disease?
    Gallino A; Häberli A; Straub PW; Steinbrunn W; Turina M; Rothlin ME
    Eur Heart J; 1987 Jul; 8(7):734-7. PubMed ID: 2958280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinopeptide A and platelet factor levels in unstable angina pectoris.
    Théroux P; Latour JG; Léger-Gauthier C; De Lara J
    Circulation; 1987 Jan; 75(1):156-62. PubMed ID: 2947740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
    Rosove MH; Hocking WG; Harwig SS; Perloff JK
    Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.
    van Hulsteijn H; Kolff J; Briët E; van der Laarse A; Bertina R
    Am Heart J; 1984 Jan; 107(1):39-45. PubMed ID: 6197872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions.
    Watkins MW; Luetmer PA; Schneider DJ; Witmer WT; Vaitkus PT; Sobel BE
    Cathet Cardiovasc Diagn; 1998 Jul; 44(3):257-64. PubMed ID: 9676792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood coagulation and fibrinolysis in ischemic heart disease].
    Sakamoto T; Ogawa H; Miyao Y; Yasue H
    Rinsho Byori; 1994 Jan; 42(1):39-44. PubMed ID: 8107282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased fibrinopeptide A during anginal attacks in patients with variant angina.
    Irie T; Imaizumi T; Matuguchi T; Koyanagi S; Kanaide H; Takeshita A; Nakamura M
    J Am Coll Cardiol; 1989 Sep; 14(3):589-94; discussion 595-6. PubMed ID: 2768708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
    Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
    Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibrinopeptide A and beta-thromboglobulin in patients with chest pain.
    Douglas JT; Lowe GD; Forbes CD; Prentice CR
    Thromb Haemost; 1983 Aug; 50(2):541-2. PubMed ID: 6195751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinopeptide A excretion in urine: a marker of the cumulative thrombin activity in stable versus unstable angina patients.
    Ardissino D; Gamba MG; Merlini PA; Rolla A; Barberis P; Demicheli G; Testa S; Bruno N; Specchia G
    Am J Cardiol; 1991 Sep; 68(7):58B-63B. PubMed ID: 1892068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian variation in fibrinolytic activity in patients with variant angina.
    Masuda T; Ogawa H; Miyao Y; Yu Q; Misumi I; Sakamoto T; Okubo H; Okumura K; Yasue H
    Br Heart J; 1994 Feb; 71(2):156-61. PubMed ID: 8130024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus.
    Rosove MH; Frank HJ; Harwig SS
    Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of fibrinopeptide A and beta-thromboglobulin in acute deep venous thrombosis and pulmonary embolism.
    van Hulsteijn H; Briët E; Koch C; Hermans J; Bertina R
    Acta Med Scand; 1982; 211(5):323-30. PubMed ID: 6180602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia.
    Gallino A; Haeberli A; Baur HR; Straub PW
    Circulation; 1985 Jul; 72(1):27-30. PubMed ID: 2408785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variation in variant angina.
    Waters DD; Miller DD; Bouchard A; Bosch X; Theroux P
    Am J Cardiol; 1984 Jul; 54(1):61-4. PubMed ID: 6741840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
    Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
    Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of fibrinopeptide A in surgery].
    Fuwa S
    Nihon Geka Gakkai Zasshi; 1984 Mar; 85(3):191-205. PubMed ID: 6236358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.